Mechanism tag
Intranasal peptides
Peptides studied principally via the intranasal route, exploiting nose-to-brain transport along the olfactory and trigeminal pathways.
Semax
A synthetic heptapeptide analogue of ACTH(4-10) developed in Russia for cognitive enhancement, neuroprotection, and stroke recovery research.
Read profileSelank
A synthetic heptapeptide analogue of tuftsin developed for anxiolytic and immunomodulatory research, with measurable effects on attention and mood.
Read profilePinealon
A short tripeptide bioregulator studied in Russian gerontology research for neuroprotective and anti-ageing effects on the central nervous system.
Read profileN-Acetyl Semax Amidate
A chemically protected analogue of Semax with N-terminal acetylation and C-terminal amidation, conferring substantially extended half-life and improved potency in research.
Read profileN-Acetyl Selank Amidate
Chemically protected analogue of Selank with extended half-life through N-terminal acetylation and C-terminal amidation; same anxiolytic profile as the parent compound with longer duration.
Read profileDavunetide
An 8-amino-acid ADNP-derived peptide (NAPVSIPQ) evaluated in multiple neurodegenerative disease trials — the flagship clinical-trial peptide in the synaptogenic / neuroprotective family.
Read profileOxytocin (intranasal)
The endogenous nonapeptide 'social bonding' hormone, studied via intranasal delivery for social cognition, anxiety, and trust-related research endpoints — one of the most-researched peptides in cognitive neuroscience.
Read profileDDAVP (Desmopressin)
A licensed synthetic vasopressin analogue with documented memory-modulation effects — one of the classical vasopressin-family cognitive research peptides with the deepest historical literature.
Read profileCortagen
A synthetic tetrapeptide from the Khavinson bioregulator programme (Ala-Glu-Asp-Pro), positioned as a brain-cortex-targeted bioregulator complementing Pinealon and Cortexin.
Read profileVesugen
A Khavinson vascular short peptide (Lys-Glu-Asp) targeting vascular-endothelial gene expression, with cerebrovascular research relevance in cognitive-ageing and stroke-recovery contexts.
Read profileN-Acetyl Epitalon Amidate
A chemically protected analogue of Epitalon with N-terminal acetylation and C-terminal amidation — same pineal-directed pharmacology as parent Epitalon with extended half-life, mirroring the NA-Semax and NA-Selank pattern.
Read profileDGAVP
A classical De Wied-laboratory vasopressin analogue engineered to preserve memory-relevant central effects while eliminating the pressor effect of parent vasopressin — the reference vasopressin-family cognitive research peptide of the 1970s-80s.
Read profileMIF-1
A tripeptide originally identified as an inhibitor of melanocyte-stimulating hormone release, with a distinctive research history spanning memory modulation, dopamine-receptor allosteric effects, and Parkinson's-disease-adjacent research applications.
Read profileTRH (Thyrotropin-releasing hormone)
The endogenous hypothalamic tripeptide that stimulates thyroid-stimulating hormone release, with distinctive research history in cognitive effects, arousal, mood modulation, and neuroprotective applications separated from the primary thyroid-axis pharmacology.
Read profileVasopressin
The endogenous nonapeptide antidiuretic hormone with distinctive central memory-modulation effects — the parent compound of the classical vasopressin-family cognitive research programme and the direct hormone from which DDAVP and DGAVP were engineered.
Read profile